Presentation is loading. Please wait.

Presentation is loading. Please wait.

Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance.

Similar presentations


Presentation on theme: "Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance."— Presentation transcript:

1 Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies  Farah Sahoo, Joshua A. Hill, Hu Xie, Wendy Leisenring, Jessica Yi, Sonia Goyal, Louise E. Kimball, Ingi Lee, Sachiko Seo, Chris Davis, Stephen A. Pergam, Mary E. Flowers, Kai-Li Liaw, Leona Holmberg, Michael Boeckh  Biology of Blood and Marrow Transplantation  Volume 23, Issue 3, Pages (March 2017) DOI: /j.bbmt Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Cumulative incidence curves of time to HZ episode. (A) Demonstrates the cumulative incidence of first HZ episodes in the entire cohort over time. One hundred ninety-four patients had an initial HZ episode within 5 years after autologous HCT with a cumulative incidence of 21% (95% CI, 18% to 24%). (B) Demonstrates the cumulative incidence of recurrent HZ episodes over time. Thirty-one patients had a recurrent episode of HZ after autologous HCT. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance."

Similar presentations


Ads by Google